← All trials
NCT04380935
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 11, 2020
- Primary completion
- Aug 31, 2020
- Completion date
- Aug 31, 2020
- First posted
- May 8, 2020
- Last posted
- May 8, 2020
- Enrollment
- 60
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of IndonesiaLead sponsor
- University of IndonesiaReponsible party - principal investigator
- University of IndonesiaCollaborator
- Faculty of Medicine Universitas Indonesia - Dr Cipto Mangunkusumo HospitalStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.